128 related articles for article (PubMed ID: 12684657)
1. Loss of heterozygosity and p53 polymorphism Pro72Arg in a young patient with medulloblastoma.
Sardi I; Giunti L; Donati P; Lacitignola L; Tucci F; Sardo L; Giovannucci Uzielli ML; Bernini G
Oncol Rep; 2003; 10(3):773-5. PubMed ID: 12684657
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
Adesina AM; Nalbantoglu J; Cavenee WK
Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
[TBL] [Abstract][Full Text] [Related]
4. Infrequent p53 gene mutations in medulloblastomas.
Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
[TBL] [Abstract][Full Text] [Related]
5. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
Emadian SM; McDonald JD; Gerken SC; Fults D
Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
Pietsch T; Koch A; Wiestler OD
Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
[TBL] [Abstract][Full Text] [Related]
7. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
McDonald JD; Daneshvar L; Willert JR; Matsumura K; Waldman F; Cogen PH
Genomics; 1994 Sep; 23(1):229-32. PubMed ID: 7829075
[TBL] [Abstract][Full Text] [Related]
8. A novel case of a CAT to AAT transversion in codon 179 of the p53 gene in a supratentorial primitive neuroectodermal tumor harbored by a young girl. Case report and review of the literature.
Postovsky S; Ben Arush MW; Elhasid R; Davidson S; Leshanski L; Vlodavsky E; Guilburd JN; Amikam D
Oncology; 2003; 65(1):46-51. PubMed ID: 12837982
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
10. No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma).
Biegel JA; Wentz E
Genes Chromosomes Cancer; 1997 Feb; 18(2):143-6. PubMed ID: 9115964
[TBL] [Abstract][Full Text] [Related]
11. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
13. Primitive neuroectodermal tumor in the cerebellopontine angle with isochromosome 17q presenting as meningioma in a woman 26 years of age.
Izycka-Swieszewska E; Debiec-Rychter M; Kloc W
Clin Neuropathol; 2003; 22(2):66-70. PubMed ID: 12670052
[TBL] [Abstract][Full Text] [Related]
14. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
15. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
16. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.
Philipova T; Baryawno N; Hartmann W; Pietsch T; Druid H; Johnsen JI; Ekström TJ
Int J Oncol; 2011 Mar; 38(3):843-9. PubMed ID: 21184030
[TBL] [Abstract][Full Text] [Related]
17. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
18. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
19. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced glioblastoma in a medulloblastoma patient: a case report with molecular features.
Gessi M; Maderna E; Guzzetti S; Cefalo G; Massimino M; Solero CL; Finocchiaro G; Pollo B
Neuropathology; 2008 Dec; 28(6):633-9. PubMed ID: 18384514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]